Shidasp S.
- Country
- France
- Department
- Service de réanimation polyvalente
Research Overview
- Evaluation of Levetiracetam for Delirium Prevention in Adult ICU Patients with Septic Shock: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Hydrocortisone and Fludrocortisone Efficacy in Critically Ill Patients with Corticosteroid Insufficiency: A Randomized Controlled Trial
- Evaluation of High-Dose Intravenous Ascorbic Acid on Mortality and Organ Dysfunction in Septic ARDS Patients: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 28 of 53 partner sites.
Specializations
Intensive Care Medicine
This investigator specializes in managing severe infections and critical conditions in intensive care unit (ICU) settings, with particular emphasis on treating ESBL-producing Enterobacteriaceae infections and exploring alternative antimicrobial strategies.
- Carbapenem-sparing treatments
- Severe bacterial infections
- Antimicrobial resistance
Sepsis Management
The investigator focuses on innovative approaches to septic shock treatment, including neurological complications and hormonal interventions. Their work encompasses both preventive strategies and therapeutic interventions for sepsis-related conditions.
- Delirium prevention in sepsis
- Corticosteroid therapy
- Organ dysfunction management
Critical Care Therapeutics
Research interests extend to novel therapeutic approaches for critical illness, including vitamin C interventions and hormone replacement strategies for critical illness-related corticosteroid insufficiency.
- ARDS treatment
- Endocrine therapy in critical care
- Organ support strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.